Sale!

PIEZO2 Gene Arthrogryposis Distal Type 3 Genetic Test

Original price was: $700.Current price is: $500.

-29%

The PIEZO2 Gene Arthrogryposis Distal Type 3 NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the PIEZO2 gene responsible for distal arthrogryposis type 3. This specialized genetic test utilizes next-generation sequencing technology to detect specific genetic variations that cause congenital joint contractures, musculoskeletal abnormalities, and associated dermatological manifestations. The test provides crucial information for accurate diagnosis, family planning decisions, and personalized treatment approaches. Available for only $500 USD, this advanced genetic analysis helps patients and healthcare providers understand the underlying genetic causes of distal arthrogryposis type 3, enabling better management strategies and improved quality of life outcomes.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

PIEZO2 Gene Arthrogryposis Distal Type 3 NGS Genetic DNA Test

Comprehensive Genetic Analysis for Musculoskeletal Disorders

The PIEZO2 Gene Arthrogryposis Distal Type 3 NGS Genetic DNA Test represents a cutting-edge diagnostic approach for identifying genetic mutations associated with distal arthrogryposis type 3. This specialized genetic test provides crucial insights into the molecular basis of congenital joint contractures and associated musculoskeletal abnormalities, offering patients and healthcare providers definitive diagnostic information for informed medical decision-making.

What This Test Measures and Detects

Our advanced NGS genetic testing specifically targets the PIEZO2 gene, which encodes a mechanosensitive ion channel protein essential for proper musculoskeletal development and function. The test identifies:

  • Pathogenic mutations in the PIEZO2 gene sequence
  • Single nucleotide variants (SNVs) and small insertions/deletions
  • Copy number variations affecting the PIEZO2 locus
  • Genetic markers associated with distal arthrogryposis type 3 phenotype
  • Inheritance patterns and familial risk assessment

Who Should Consider This Genetic Test

This specialized genetic testing is recommended for individuals presenting with:

  • Congenital joint contractures affecting hands and feet
  • Limited range of motion in distal joints from birth
  • Family history of distal arthrogryposis type 3
  • Unexplained musculoskeletal abnormalities in infancy or childhood
  • Associated dermatological manifestations including skin abnormalities
  • Diagnostic uncertainty regarding congenital joint disorders
  • Family planning considerations with known familial risk

Key Benefits of PIEZO2 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages:

  • Accurate Diagnosis: Confirms or rules out distal arthrogryposis type 3 with high precision
  • Personalized Treatment: Enables targeted therapeutic approaches based on genetic findings
  • Family Planning: Provides crucial information for reproductive decision-making
  • Early Intervention: Facilitates timely management strategies for optimal outcomes
  • Genetic Counseling: Supports informed discussions about inheritance patterns and risks
  • Research Contribution: Advances understanding of PIEZO2-related disorders

Understanding Your Test Results

Our comprehensive genetic report provides detailed interpretation of your results:

  • Positive Result: Indicates the presence of pathogenic PIEZO2 mutations, confirming distal arthrogryposis type 3 diagnosis
  • Negative Result: Suggests absence of detectable PIEZO2 mutations, though clinical correlation remains essential
  • Variant of Uncertain Significance: Identifies genetic changes requiring further clinical evaluation
  • Carrier Status: Determines inheritance patterns and familial risk assessment

All results are accompanied by detailed clinical interpretation and recommendations from our expert genetic counseling team.

Test Pricing Information

Test Name Discount Price Regular Price
PIEZO2 Gene Arthrogryposis Distal Type 3 NGS Genetic DNA Test $500 USD $700 USD

Nationwide Testing Availability

We proudly offer comprehensive genetic testing services across the United States, with convenient locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more cities nationwide. Our state-of-the-art laboratories ensure consistent, high-quality testing regardless of your location.

Take the Next Step Toward Genetic Clarity

Don’t let uncertainty about musculoskeletal symptoms affect your quality of life. Our specialized PIEZO2 genetic testing provides the answers you need for informed healthcare decisions. With results available in 3-4 weeks and comprehensive genetic counseling support, you’ll receive the clarity and guidance necessary for optimal health management.

Book your PIEZO2 Gene Arthrogryposis Distal Type 3 NGS Genetic DNA Test today by calling our dedicated genetic testing specialists at +1(267) 388-9828 or schedule your appointment online. Take control of your genetic health journey with confidence and precision.